|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
6,874 |
$1,332,387.42 |
7.09% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
14,477 |
$1,316,683.15 |
7.00% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
5,788 |
$1,303,283.96 |
6.93% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
25,812 |
$1,257,560.64 |
6.69% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
49,185 |
$1,254,709.35 |
6.67% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
4,093 |
$838,287.33 |
4.46% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
831 |
$821,543.22 |
4.37% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,522 |
$721,530.32 |
3.84% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
2,116 |
$716,160.20 |
3.81% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
1,048 |
$706,928.40 |
3.76% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
1,557 |
$668,295.54 |
3.55% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
5,390 |
$660,598.40 |
3.51% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
57,716 |
$646,419.20 |
3.44% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,363 |
$625,903.23 |
3.33% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,893 |
$467,627.16 |
2.49% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
2,864 |
$392,683.04 |
2.09% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
3,034 |
$371,968.40 |
1.98% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
3,081 |
$333,240.96 |
1.77% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
4,349 |
$321,043.18 |
1.71% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
6,067 |
$260,729.34 |
1.39% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,493 |
$259,035.50 |
1.38% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
406 |
$244,724.62 |
1.30% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
9,430 |
$215,569.80 |
1.15% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
3,559 |
$195,495.87 |
1.04% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,144 |
$173,918.64 |
0.92% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
2,317 |
$162,491.21 |
0.86% |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Biotechnology |
3,763 |
$156,164.50 |
0.83% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
1,944 |
$140,842.80 |
0.75% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
948 |
$139,630.92 |
0.74% |
| NewAmsterdam Pharma Company N.V. |
NAMS |
N62509109 |
Biotechnology |
3,446 |
$137,460.94 |
0.73% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
11,366 |
$135,823.70 |
0.72% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,229 |
$120,085.59 |
0.64% |
| Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
1,404 |
$120,126.24 |
0.64% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
609 |
$117,957.21 |
0.63% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
561 |
$113,883.00 |
0.61% |
| BridgeBio Pharma, Inc. |
BBIO |
10806X102 |
Biotechnology |
1,601 |
$106,594.58 |
0.57% |
| Ligand Pharmaceuticals Inc. (Class B) |
LGND |
53220K504 |
Biotechnology |
513 |
$107,063.10 |
0.57% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
190 |
$102,885.00 |
0.55% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,140 |
$95,634.00 |
0.51% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,189 |
$93,942.89 |
0.50% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
2,827 |
$87,947.97 |
0.47% |
| Supernus Pharmaceuticals, Inc. |
SUPN |
868459108 |
Pharmaceuticals |
1,837 |
$84,704.07 |
0.45% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
185 |
$83,610.75 |
0.44% |
| Mirum Pharmaceuticals, Inc. |
MIRM |
604749101 |
Biotechnology |
1,123 |
$80,092.36 |
0.43% |
| Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
804 |
$80,287.44 |
0.43% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,296 |
$78,511.68 |
0.42% |
| Tempus AI, Inc. (Class A) |
TEM |
88023B103 |
Biotechnology |
1,093 |
$78,215.08 |
0.42% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
4,802 |
$76,976.06 |
0.41% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
3,189 |
$75,643.08 |
0.40% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
4,525 |
$64,707.50 |
0.34% |
| US Dollar |
$USD |
|
Other |
56,844 |
$56,843.67 |
0.30% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|